A series of new 2-aminopyrrole derivatives [2-amino-1-aryl-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1H-pyrrole-3-carboxamides IIa-h] were synthesized via the reaction of 4-arylamino-2-tert-butyl-2,5-dihydro-5-oxofuran-2-ylacetates (Ia-h) with 2-cyano-N-(thiazol-2-yl)acetamide in the presence of Et3N. Studies of the biological activity of the synthesized compounds found that they possessed low toxicity and that 2-amino-1-(2-bromophenyl)-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1H-pyrrole-3-carboxamide (IIb) and 2-amino-1-(2,4-dichlorophenyl)-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1H-pyrrole-3-carboxamide (IIg) exhibited radical-binding activity greater than that of trolox and cytotoxic activity against gastrointestinal stromal tumor (GIST) cells, including those resistant to the target drug imatinib (Glivec). The cytotoxic activity of the synthesized compounds was comparable with that of doxorubicin chemotherapeutics and exceeded significantly those of etoposide, paclitaxel, and hydroxyurea. Apossible molecular mechanism of action of the synthesized compounds might be their ability to disrupt cell division and induce selective accumulation of M-phase cells with subsequent death by a mitotic catastrophe pathway.
Similar content being viewed by others
References
G. D. Demetri, M. von Mehren, C. D. Blanke, et al., N. Engl. J. Med., 347, 472 – 480 (2002).
J. Verweij, P. G. Casali, J. Zalcberg, et al., Lancet, 364, 1127 – 1133 (2004).
A. W. Gramza, C. L. Corless, and M. C. Heinrich, Clin. Cancer Res., 15, 7510 – 7518 (2009).
T. Taguchi, H. Sonobe, S. Toyonaga, I. Yamasaki, et al., Lab. Invest., 82, 663 – 665 (2002).
S. Boichuk, D. J. Lee, K. R. Mehalek, et al., Cancer Res., 74(4), 1200 – 1213 (2014).
S. S. Zykova, A. R. Galembikova, B. R. Ramazanov, et al., Khim.-farm. Zh., 49(12), 19 – 23 (2015); S. S. Zykova, A. R. Galembikova, B. R. Ramazanov, et al., Khim.-farm. Zh., 49(12), 817 – 820 (2016).
S. Boichuk, A. Galembikova, S. Zykova, B. Ramazanov, et al., Anti-Cancer Drugs, 27(7), 620 – 634 (2016).
S. S. Kharitonova, N. M. Igidov, A. V. Zakhmatov, and A. E. Rubtsov, Zh. Org. Khim., 49(2), 252 (2013); S. S. Kharitonova, N. M. Igidov, A. V. Zakhmatov, and A. E. Rubtsov, Russ. J. Org. Chem., 49, 243 (2013).
S. S. Zykova, A. A. Darovskikh, T. F. Odegova, et al., Khim.- farm. Zh., 49(10), 15 – 18 (2015); S. S. Zykova, A. A. Darovskikh, T. F. Odegova, et al., Pharm. Chem. J., 49(10), 657 – 660 (2016).
S. S. Zykova, S. V. Boichuk, A. R. Galembikova, et al., Tsitologiya, 56(6), 439 – 442 (2014).
S. S. Zykova and S. V. Boichuk, in: Proceedings of the XVIIIth International Scientific Conference “Oncology – XXIst Century” [in Russian], Brussels, Belgium (2013), pp. 75 – 78.
N. M. Igidov, A. V. Zakhmatov, and A. E. Rubtsov, Zh. Org. Khim., 52(7), 981 (2016).
A. V. Tyuneva, N. M. Igidov, and N. N. Koryagina, Zh. Org. Khim., 47, 266 (2011); A. V. Tyuneva, N. M. Igidov, and N. N. Koryagina, Russ. J. Org. Chem., 47, 258 (2011).
P. Molyneux, Songklanakarin J. Sci. Technol., 26, No. 2, 211 – 219 (2004).
S. S. Zykova, S. V. Boichuk, A. R. Galembikova, et al., RU Pat. No. 2,605,091, Dec. 10, 2016; “2-Amino-1-aryl-5-(3,3- dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1Hpyrrole-3-carboxamides, exhibiting antitumour and antiradical activity, synthesis method thereof and pharmaceutical composition based thereon”.
I. V. Berezovskaya, Khim.-farm. Zh., 37(3), 32 – 34 (2003).
Acknowledgments
The research was financially supported by the Russian Science Foundation (RSF) Grant No. 14-15-00342.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 52, No. 3, pp. 10 – 16, March, 2018.
Rights and permissions
About this article
Cite this article
Zykova, S.S., Igidov, N.M., Zakhmatov, A.V. et al. Synthesis and Biological Activity of 2-amino-1-aryl-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1h-pyrrole-3-carboxamides. Pharm Chem J 52, 198–204 (2018). https://doi.org/10.1007/s11094-018-1790-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-018-1790-9